Literature DB >> 26608452

Retinal Dystrophy and Optic Nerve Pathology in the Mouse Model of Mucolipidosis IV.

Yulia Grishchuk1, Katherine G Stember2, Aya Matsunaga2, Ana M Olivares3, Nelly M Cruz3, Victoria E King2, Daniel M Humphrey2, Shirley L Wang2, Alona Muzikansky4, Rebecca A Betensky5, Wallace B Thoreson6, Neena Haider3, Susan A Slaugenhaupt2.   

Abstract

Mucolipidosis IV is a debilitating developmental lysosomal storage disorder characterized by severe neuromotor retardation and progressive loss of vision, leading to blindness by the second decade of life. Mucolipidosis IV is caused by loss-of-function mutations in the MCOLN1 gene, which encodes the transient receptor potential channel protein mucolipin-1. Ophthalmic pathology in patients includes corneal haze and progressive retinal and optic nerve atrophy. Herein, we report ocular pathology in Mcoln1(-/-) mouse, a good phenotypic model of the disease. Early, but non-progressive, thinning of the photoreceptor layer, reduced levels of rhodopsin, disrupted rod outer segments, and widespread accumulation of the typical storage inclusion bodies were the major histological findings in the Mcoln1(-/-) retina. Electroretinograms showed significantly decreased functional response (scotopic a- and b-wave amplitudes) in the Mcoln1(-/-) mice. At the ultrastructural level, we observed formation of axonal spheroids and decreased density of axons in the optic nerve of the aged (6-month-old) Mcoln1(-/-) mice, which indicates progressive axonal degeneration. Our data suggest that mucolipin-1 plays a role in postnatal development of photoreceptors and provides a set of outcome measures that can be used for ocular therapy development for mucolipidosis IV.
Copyright © 2016 American Society for Investigative Pathology. Published by Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26608452      PMCID: PMC4715222          DOI: 10.1016/j.ajpath.2015.09.017

Source DB:  PubMed          Journal:  Am J Pathol        ISSN: 0002-9440            Impact factor:   4.307


  52 in total

Review 1.  CUPpling calcium to lysosomal biogenesis.

Authors:  Robert C Piper; J Paul Luzio
Journal:  Trends Cell Biol       Date:  2004-09       Impact factor: 20.808

2.  Identification of the gene causing mucolipidosis type IV.

Authors:  R Bargal; N Avidan; E Ben-Asher; Z Olender; M Zeigler; A Frumkin; A Raas-Rothschild; G Glusman; D Lancet; G Bach
Journal:  Nat Genet       Date:  2000-09       Impact factor: 38.330

3.  Mucolipidosis type IV is caused by mutations in a gene encoding a novel transient receptor potential channel.

Authors:  M Sun; E Goldin; S Stahl; J L Falardeau; J C Kennedy; J S Acierno; C Bove; C R Kaneski; J Nagle; M C Bromley; M Colman; R Schiffmann; S A Slaugenhaupt
Journal:  Hum Mol Genet       Date:  2000-10-12       Impact factor: 6.150

4.  Noninvasive diagnosis and ophthalmic features of mucolipidosis type IV.

Authors:  Janine A Smith; Chi-Chao Chan; Ehud Goldin; Raphael Schiffmann
Journal:  Ophthalmology       Date:  2002-03       Impact factor: 12.079

Review 5.  The molecular basis of mucolipidosis type IV.

Authors:  Susan A Slaugenhaupt
Journal:  Curr Mol Med       Date:  2002-08       Impact factor: 2.222

6.  Functional links between mucolipin-1 and Ca2+-dependent membrane trafficking in mucolipidosis IV.

Authors:  Janice M LaPlante; C P Ye; Stephen J Quinn; Ehud Goldin; Edward M Brown; Susan A Slaugenhaupt; Peter M Vassilev
Journal:  Biochem Biophys Res Commun       Date:  2004-10-01       Impact factor: 3.575

7.  Caenorhabditis elegans functional orthologue of human protein h-mucolipin-1 is required for lysosome biogenesis.

Authors:  Sebastian Treusch; Sarah Knuth; Susan A Slaugenhaupt; Ehud Goldin; Barth D Grant; Hanna Fares
Journal:  Proc Natl Acad Sci U S A       Date:  2004-03-15       Impact factor: 11.205

8.  Cloning of the gene encoding a novel integral membrane protein, mucolipidin-and identification of the two major founder mutations causing mucolipidosis type IV.

Authors:  M T Bassi; M Manzoni; E Monti; M T Pizzo; A Ballabio; G Borsani
Journal:  Am J Hum Genet       Date:  2000-09-29       Impact factor: 11.025

9.  The renewal of photoreceptor cell outer segments.

Authors:  R W Young
Journal:  J Cell Biol       Date:  1967-04       Impact factor: 10.539

10.  Overexpression of wild-type and mutant mucolipin proteins in mammalian cells: effects on the late endocytic compartment organization.

Authors:  M Manzoni; E Monti; R Bresciani; A Bozzato; S Barlati; M T Bassi; G Borsani
Journal:  FEBS Lett       Date:  2004-06-04       Impact factor: 4.124

View more
  11 in total

1.  Novel degenerative and developmental defects in a zebrafish model of mucolipidosis type IV.

Authors:  Huiqing Li; Wuhong Pei; Sivia Vergarajauregui; Patricia M Zerfas; Nina Raben; Shawn M Burgess; Rosa Puertollano
Journal:  Hum Mol Genet       Date:  2017-07-15       Impact factor: 6.150

2.  Acid Ceramidase Deficiency in Mice Leads to Severe Ocular Pathology and Visual Impairment.

Authors:  Fabian P S Yu; Benjamin S Sajdak; Jakub Sikora; Alexander E Salmon; Murtaza S Nagree; Jiří Gurka; Iris S Kassem; Daniel M Lipinski; Joseph Carroll; Jeffrey A Medin
Journal:  Am J Pathol       Date:  2018-11-23       Impact factor: 4.307

Review 3.  Current concepts in the neuropathogenesis of mucolipidosis type IV.

Authors:  Lauren C Boudewyn; Steven U Walkley
Journal:  J Neurochem       Date:  2018-08-30       Impact factor: 5.372

4.  Fingolimod phosphate inhibits astrocyte inflammatory activity in mucolipidosis IV.

Authors:  Laura D Weinstock; Amanda M Furness; Shawn S Herron; Sierra S Smith; Sitara B Sankar; Samantha G DeRosa; Dadi Gao; Molly E Mepyans; Anna Scotto Rosato; Diego L Medina; Ayelet Vardi; Natalia S Ferreira; Soo Min Cho; Anthony H Futerman; Susan A Slaugenhaupt; Levi B Wood; Yulia Grishchuk
Journal:  Hum Mol Genet       Date:  2018-08-01       Impact factor: 6.150

5.  Progress in elucidating pathophysiology of mucolipidosis IV.

Authors:  Albert Misko; Levi Wood; Kirill Kiselyov; Susan Slaugenhaupt; Yulia Grishchuk
Journal:  Neurosci Lett       Date:  2021-05-11       Impact factor: 3.197

6.  Robust lysosomal calcium signaling through channel TRPML1 is impaired by lysosomal lipid accumulation.

Authors:  Néstor Más Gómez; Wennan Lu; Jason C Lim; Kirill Kiselyov; Keith E Campagno; Yulia Grishchuk; Susan A Slaugenhaupt; Bruce A Pfeffer; Steven J Fliesler; Claire H Mitchell
Journal:  FASEB J       Date:  2018-01-04       Impact factor: 5.834

7.  Mitochondrial respiratory chain deficiency inhibits lysosomal hydrolysis.

Authors:  Lorena Fernandez-Mosquera; King Faisal Yambire; Renata Couto; Leonardo Pereyra; Kamil Pabis; Amy H Ponsford; Cátia V Diogo; Massimiliano Stagi; Ira Milosevic; Nuno Raimundo
Journal:  Autophagy       Date:  2019-03-27       Impact factor: 16.016

8.  Early evidence of delayed oligodendrocyte maturation in the mouse model of mucolipidosis type IV.

Authors:  Molly Mepyans; Livia Andrzejczuk; Jahree Sosa; Sierra Smith; Shawn Herron; Samantha DeRosa; Susan A Slaugenhaupt; Albert Misko; Yulia Grishchuk; Kirill Kiselyov
Journal:  Dis Model Mech       Date:  2020-07-30       Impact factor: 5.758

9.  Peripheral Inflammatory Cytokine Signature Mirrors Motor Deficits in Mucolipidosis IV.

Authors:  Albert L Misko; Laura D Weinstock; Sitara B Sankar; Amanda Furness; Yulia Grishchuk; Levi B Wood
Journal:  Cells       Date:  2022-02-04       Impact factor: 6.600

Review 10.  Mouse Models of Inherited Retinal Degeneration with Photoreceptor Cell Loss.

Authors:  Gayle B Collin; Navdeep Gogna; Bo Chang; Nattaya Damkham; Jai Pinkney; Lillian F Hyde; Lisa Stone; Jürgen K Naggert; Patsy M Nishina; Mark P Krebs
Journal:  Cells       Date:  2020-04-10       Impact factor: 7.666

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.